Cocaine: History, Social Implications, and Toxicity-A Review

Disease-a-Month

Volumn 55, Issue 1, 2009, Pages 6-38

  Goldstein, Rachel A ^a   DesLauriers, Carol ^a   Burda, Anthony M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; AMFEBUTAMONE; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BICARBONATE; BUTYROPHENONE; CANNABIS; COCAINE; DIAZEPAM; DILTIAZEM; FLUOXETINE; INFUSION FLUID; LIDOCAINE; LORAZEPAM; MAGNESIUM SULFATE; MANNITOL; NICOTINE; NITRATE; PHENOTHIAZINE; PHENTOLAMINE; QUININE; STARCH; STRYCHNINE; SUGAR; SUXAMETHONIUM; TALC; TRANYLCYPROMINE; VERAPAMIL;

ABSORPTION; ACUTE LUNG INJURY; AMNION FLUID ANALYSIS; ANGINA PECTORIS; AORTA DISSECTION; ASTHMA; BLOOD TESTIS BARRIER; BRADYCARDIA; BRONCHIOLITIS OBLITERANS; BRONCHOSPASM; CARDIOTOXICITY; COCA; CONGESTIVE CARDIOMYOPATHY; CONVULSION; DELIRIUM; DRUG ABUSE; DRUG MANUFACTURE; DRUG USE; GOODPASTURE SYNDROME; HAIR ANALYSIS; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEMODIALYSIS; HUMAN; HYPERTENSION; LUNG BURN; LUNG EDEMA; LUNG HEMORRHAGE; LUNG INFILTRATE; MECONIUM; METABOLISM; NEUROTOXICITY; NONHUMAN; OXYGEN THERAPY; PNEUMOMEDIASTINUM; PNEUMOTHORAX; PRENATAL EXPOSURE; REVIEW; RHABDOMYOLYSIS; SALIVA ANALYSIS; SCREENING TEST; SINUS TACHYCARDIA; SOCIAL ASPECT; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA; TACHYCARDIA; THORAX PAIN; TORSADE DES POINTES; URINALYSIS; URINARY EXCRETION; VASOCONSTRICTION;

ANESTHETICS, LOCAL; COCAINE; COCAINE-RELATED DISORDERS; DRUG INTERACTIONS; HISTORY, 15TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; RHABDOMYOLYSIS; SOCIAL CHANGE; SUBSTANCE ABUSE DETECTION; UNITED STATES; VASOCONSTRICTOR AGENTS;

EID: 57149085055     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2008.10.002     Document Type: Review

References (95)

1. Altman A.J., Albert D.M., and Fournier G.A. Cocaine's use in ophthalmology: our 100 year heritage. Surv Ophthalmol 29 (1985) 300-307
2. Gay G.R., Inaba D.S., Sheperd C.W., et al. Cocaine: history, epidemiology, human pharmacology and treatment. A perspective on a new debut for an old girl. Clin Toxicol 8 (1975) 149-178
3. Piek J, Lidke G, Terberger Th. Chirurgische Universitatsklinik Rostock, Abeilung fur Neurochirurgie, Rostock. Ancient trephinations in Neolithic people-evidence for stone age neurosurgery? Nat Proc hdl:10101/npre.2008.1615.1. Posted 21 Feb 2008.
4. Monardes N. Joyfull Newes Out of the Newe Founde Worlde (1925), Alfred Knopf, New York, NY
5. May C.D. How Coca-Cola obtains its coca. The New York Times (1998) July 1. Accessed December 4, 2007
6. Benson D. Coca kick in drinks spurs export fears. The Washington Times (2004) April 20
7. Johnson C. The Legal Importation of Coca Leaf. http://www.uic.edu/classes/osci/osci590/9_3%20The%20Legal%20Importation%20of%20Coca%20Leaf.htm. Accessed on February 11, 2007.
8. Brecher E.M. Editors of Consumer Reports Magazine. The Consumers Union Report on licit and illicit drugs. Consumer Reports Magazine (1972)
9. 63rd Congress. The Harrison Narcotic Act (1914). Public Law No. 223, approved December 17, 1914.
10. National Survey on Drug Use and Health. http://www.samhsa.gov/ Accessed June 1, 2008
11. Drug Abuse Warning Network, 2004: National estimates of drug-related emergency department visits. U.S. Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. http://DAWNinfo.samhsa.gov/.
12. Office of Applied Studies. Year-end 1999 emergency department data from drug abuse warning network. Rockville, MD: Substance Abuse and Mental Health Services Administration, August 2000. DHSS publication no. (SMA)00-3462.
13. Traub S.J., Hoffman R.S., and Nelson L.S. Body packing-the internal concealment of illicit drugs. New Engl J Med 349 26 (2003) 2519-2526
14. Caruana D.S., Weinbach B., Goerg D., et al. Cocaine-packet ingestion. Ann Intern Med 100 1 (1984) 73-74
15. Kashani J., and Ruha A.M. Methamphetamine toxicity secondary to intravaginal body stuffing. J Toxicol Clin Toxicol 42 7 (2004) 987-989
16. Shanti C.M., and Lucas C.E. Cocaine and the critical care challenge. Crit Care Med 31 6 (2003) 1851-1859
17. Boghdadi M.S., and Henning R.J. Cocaine: pathophysiology and clinical toxicology. Heart Lung 26 6 (1997) 466-483
18. Warner E.A. Cocaine abuse. Ann Intern Med 119 3 (1993) 226-235
19. Shannon M. Clinical toxicity of cocaine adulterants. Ann Emerg Med 17 11 (1988) 1243-1247
20. Koren G., Klein J., Forman R., et al. Hair analysis of cocaine: differentiation between systemic exposure and external contamination. J Clin Pharmacol 32 (1992) 671-675
21. Chychula N.M., and Okore C. The cocaine epidemic: a comprehensive review of use, abuse and dependence. Nurse Pract 15 7 (1990) 31-39
22. Stephens B.G., Jentzen J.M., Karch S., et al. Criteria for the interpretation of cocaine levels in human biological samples and their relation to the cause of death. Am J Forensic Med Pathol 25 1 (2004) 1-10
23. Jatlow P. Cocaethylene: pharmacologic activity and clinical significance. Ther Drug Monit 15 6 (1993) 533-536
24. McCance E.F., Price L.H., Kosten T.R., et al. Cocaethylene: pharmacology, physiology and behavioral effects in humans. J Pharmacol Exp Ther 274 (1995) 215-223
25. McKinney C.D., Postiglione K.F., and Herold D.A. Benzocaine-adulterated street cocaine in association with methemoglobinemia. Clin Chem 38 4 (1992) 596-597
26. Prasad R.S., Kodali V.R., Kuraijam G.S., et al. Acute confusion and blindness from quinine toxicity. Eur J Emerg Med 10 (2003) 353-356
27. Wood D.M., Webster E., Martinez D., et al. Case report: survival after deliberate strychnine self-poisoning, with toxicokinetic data. Crit Care 6 5 (2002) 456-459
28. O'Callaghan W.G., Joyce N., and Counihan H.E. Unusual strychnine poisoning and its treatment: report of eight cases. BMJ 285 (1982) 478
29. Ursitti F., Klein J., and Koren G. Confirmation of cocaine use during pregnancy: a critical review. Ther Drug Monit 23 4 (2001) 347-353
30. Burke W.M., Ravi N.V., Dhopesh V., et al. Prolonged presence of metabolite in urine after compulsive cocaine use. J Clin Psychiatry 51 4 (1990) 145-148
31. Weiss R.D., and Gawin F.H. Protracted elimination of cocaine metabolites in long-term, high-dose cocaine abusers. Am J Med 85 (1988) 879-880
32. Baselt R.C., and Baselt D.R. Little cross-reactivity of local anesthetics with Abuscreen, EMIT d.a.u., and TDX immunoassays for cocaine metabolite (letter). Clin Chem 33 5 (1987) 747
33. Mazor S.S., Mycyk M.B., Wills B.K., et al. Coca tea consumption causes positive urine cocaine assay. Eur J Emerg Med 13 (2006) 340-341
34. Mikkelsen S.L., and Ash K.O. Adulterants causing false negatives in illicit drug testing. Clin Chem 34 11 (1988) 2233-2236
35. Karch S.B. Introduction to the forensic pathology of cocaine. Am J Forensic Med Pathol 12 2 (1991) 126-131
36. Gruszecki A.C., Robinson C.A., Embry J.H., et al. Correlation of the incidence of cocaine and cocaethylene in hair and postmortem biologic samples. Am J Forensic Med Pathol 21 2 (2000) 166-171
37. Roldan CJ. Toxicity, Cocaine. http://www.emedicine.com/med/topic400.htm. Accessed June 1, 2008.
38. Catterall W.A., and Mackie K. Local anesthetics. In: Brunton L.J., Parker K.L., Buxton I., et al. (Eds). Goodman and Gilman's the Pharmacological Basis of Therapeutics. 11th ed. (2006), McGraw Hill, New York, NY
39. Leshner A.I. Molecular mechanisms of cocaine addiction (letter). New Engl J Med 335 2 (1996) 128-129
40. Knuepfer M. Cardiovascular disorders associated with cocaine use: myths and truths. Pharmacol Ther 97 3 (2003) 181-222
41. Hoffman R.S. Cocaine. In: Flomenbaum N.E., Goldfrank L.R., Hoffman R.S., et al. (Eds). Goldfrank's Toxicologic Emergencies. 8th ed. (2006), McGraw Hill, New York, NY 1133-1146
42. Lason W. Neurochemical and pharmacological aspects of cocaine-induced seizures. Pol J Pharmacol 53 (2001) 57-60
43. O'Dell L., George F.R., and Ritz M.C. Antidepressant drugs appear to enhance cocaine-induced toxicity. Exp Clin Psychpharmacol 8 1 (2000) 133-141
44. Liu D., Hariman R.J., and Bauman J.L. Cocaine concentration-effect relationship in the presence and absence of lidocaine: evidence of competitive binding between cocaine and lidocaine. J Pharmacol Exp Ther 276 2 (1996) 568-577
45. McCord J., Hani J., and Hollander J.E. Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association acute cardiac care committee of the council on clinical cardiology. Circulation 117 14 (2008) 1897-1907
46. Tella S.R., Schindler C.W., and Goldberg S.R. Cocaine: cardiovascular effects in relation to inhibition of peripheral neuronal monoamine uptake and central stimulation of the sympathoadrenal system. J Pharmacol Exp Ther 267 1 (1993) 153-162
47. Dattilo P.B., Hailpern S.M., Fearon K., et al. Beta blockers are associated with reduced risk of myocardial infarction after cocaine use. Ann Emerg Med 51 2 (2008) 117-125
48. Laizure S.C., Mandrell T., Gades N.M., et al. Cocaethylene metabolism and interaction with cocaine and ethanol: role of carboxylesterases. Drug Metab Dispos 31 1 (2003) 16-20
49. Foltin W., Fischman M.W., Pedroso J.J., et al. Marijuana and cocaine interactions in humans: cardiovascular consequences. Pharmacol Biochem Behav 28 4 (1987) 459-464
50. Lexi-comp Online. Lexi-Interact. 1978-2008 Lexi-Comp, Inc. Retrieved June 2008.
51. Jeffcoat A, Perez-Reyes M, Hill J. Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking. Am Soc Pharmacol Exp Therapeut 17(2):153-9.
52. Klasco RK, editor. Cocaine. POISINDEX System. Thomson Healthcare, Greenwood Village, CO (Edition expired 9/2008).
53. Leikin J., and Paloucek F. Cocaine. Poisoning and Toxicology Handbook. 4th ed. (2008), CRC Press, New York, NY 213
54. Baslet R. Cocaine. Disposition of Toxic Drugs and Chemicals in Man. 6th ed. (2002), Biomedical Publications, Foster City, CA 247-253
55. Maurer H., Sauer C., and Theobald D. Toxicokinetics of drugs of abuse: current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine. Drug Monit 28 3 (2006) 447-453
56. Jufer R., Walsh S., Cone E., et al. Effect of repeated cocaine administration on detection times in oral fluid and urine. J Anal Toxicol 30 (2006) 458-462
57. Huestis M., Darwin W., Shimomura E., et al. Cocaine and metabolites urinary excretion after controlled smoked administration. J Anal Toxicol 21 (2007) 462-468
58. Cone E., Tsadic A., Oyler H., et al. Cocaine metabolism and urinary excretion after different routes of administration. Ther Drug Monit 20 5 (1998) 556-560
59. Kolbrich E., Barnes A., Gorelick D., et al. Major and minor metabolites of cocaine in human plasma following controlled subcutaneous cocaine administration. J Anal Toxicol 30 (2006) 501-511
60. Nedamanee K., Gorelick D.A., Josephson M.A., et al. Myocardial ischemia during cocaine withdrawal. Ann Int Med 111 (1989) 876-880
61. Lange R.A., and Hillis L.D. Cardiovascular complications of cocaine use. New Engl J Med 345 (2001) 351-358
62. Tennant C.C. Cocaine use and cardiovascular complications. Department of Aged Care and Rehab, Hornsby Kur-Ring-Gai Hospital, Hornsby, NSW. Med J Aust 177 5 (2002) 260-262
63. Hollander J., Todd K., Green G., et al. Chest pain associated with cocaine: An assessment of prevalence in suburban and urban emergency departments. Ann Emerg Med 26 (1995) 671-676
64. http://www.cnn.com/2008/HEALTH/03/17/cocaine.heart.ap/index.html
65. Hollander J.E. Management of cocaine-associated myocardial ischemia. N Engl J Med 333 (1995) 1267-1272
66. Hollander J.E., Hoffman R.S., Gennis P., et al. Prospective multicenter evaluation of cocaine-associated chest pain. Cocaine Associated Chest Pain (COCHPA) Study Group. Acad Emerg Med 1 (1994) 330-339
67. Mittleman M.A., Mintzewr D., Maclure M., et al. Triggering of myocardial infarction by cocaine. Circulation 99 (1999) 2737-2741
68. Lange R.A., Cigarroa R.G., Yancy Jr. C.W., et al. Cocaine-induced coronary artery vasoconstriction. N Engl J Med 321 (1989) 1557-1562
69. Flores E.D., Lange R.A., Cigarrora R.G., et al. Effects of cocaine on coronary artery dimensions in atherosclerotic coronary artery disease: enhanced vasoconstriction at sites of significant stenoses. J Am Coll Cardiol 16 (1990) 74-79
70. Lange R.A., Cigarroa R.G., Flores E.D., et al. Potentiation of cocaine induced coronary vasoconstriction by beta-adrenergic vasoconstriction by beta-adrenergic blockade. Ann Int Med 112 (1990) 897-903
71. Mo W., Singh A.K., Arruda J.A., et al. Role of nitric oxide in cocaine induced acute hypertension. Am J Hypertens 11 (1998) 708-714
72. Roldan CJ, Habal R. Toxicity, Cocaine, WebMD, Sep 22, 2006. http://www.emedicine.com/med/topic400.htm.
73. Rezkella S.H., Mazza J.J., Kloner R.A., et al. Effects of cocaine on human platelets in healthy subjects. Am J Cardiol 72 (1993) 243-246
74. Kugelmass A.D., Oda A., Monahan K., et al. Activation of human platelets by cocaine. Circulation 88 (1993) 876-883
75. Rinder H.M., Ault K.A., Jatlow P.I., et al. Platelet alpha-granule release in cocaine users. Circulation 90 (1994) 1162-1167
76. Moliterno D.J., Lange R.A., Gerard R.D., et al. Influence of intranasal cocaine on plasma constituents associated with endogenous thrombosis and thrombolysis. Am J Med 96 (1994) 492-496
77. Kolodgie F.D., Virmani R., Cornhill J.F., et al. Increases in atherosclerosis and adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine-associated coronary vasospasm and thrombosis. J Am Coll Cardiol 17 (1991) 1553-1560
78. Kolodgie F.D., Wilson P.S., Mergner W.J., et al. Cocaine-induced increase in the permeability function of human vascular endothelial cell monolayers. Exp Mol Pathol 66 (1999) 109-122
79. Gan X., Zhang L., Berger O., et al. Cocaine enhances brain endothelial adhesion molecules and leukocyte migration. Clin Immunol 91 (1999) 68-76
80. Dattilo P.B., Fearon K., and Sohal D. B-blockers are associated with reduced risk of myocardial infarction after cocaine use. Ann Emerg Med 51 (2008) 117-125
81. Burnett LB. Toxicity, Cocaine. http://www.emedicine.com/EMERG/topic102.htm.
82. Goldfrank L.R., Flomenbaum N.E., Lewin N.A., et al. Goldfrank's Toxicologic Emergencies. 7th ed. (2002), McGraw-Hill, New York 1007-1008
83. Weiner R.S., Lockhart J.T., and Schwartz R.G. Dilated cardiomyopathy and cocaine abuse. Am J Med 81 (1986) 699-701
84. Johnson M.N., Karas S.P., Hursey T.L., et al. Cocaine binging produces left ventricular dysfunction. Circulation 80 (1989) 94(suppl 21):15
85. Konkol R.J., and Olsen G.D. Prenatal cocaine exposure (1996), CRC Press, Boca Raton, FL 47 84
86. Tashkin D.P., Kleerup E.C., Koyal S.N., et al. Acute effects of inhaled and IV cocaine on airway dynamics. Chest 110 (1996) 904-910
87. Callaway C., and Clark R.F. Hyperthermia in psychostimulant overdose. Ann Emerg Med 24 (1994) 68-76
88. Pagala M., Amaladevi B., Azad D., et al. Effect of cocaine in leakage of creatine kinase from isolated fast and slow muscles of rat. Life Sci 57 (1995) 1569-1578
89. Brazeau G., McArdles A., and Jackson M. Effects of cocaine on leakage of creatine kinase from skeletal muscle; in vitro and in vivo studies in mice. Life Sci 57 (1995) 751-756
90. Ruttenber J.A., McNally H.B., Weitl C.V., et al. Cocaine-associated rhabdomyolysis and excited delirium: different stages of the same syndrome. Am J Forensic Med Pathol 20 2 (1999) 120-127
91. Woods Jr. J.R. Maternal and transplacental effects of cocaine. Ann NY Acad Sci 846 1 (1998) 1-11
92. Chiriboga C.A., Brust J.C., Bateman D., et al. Dose-response effect of fetal cocaine exposure on newborn neurologic function. Pediatrics 103 1 (1999) 79-85
93. Chiriboga C.A. Neurological correlates if fetal cocaine exposure: cocaine effects on the developing brain. Ann NY Acad Sci 846 (1998) 109-125
94. Bauer C.R., Shankaren S., Bada H.S., et al. Acute neonatal effects of cocaine exposure during pregnancy. Arch Pediatr Adolesc Med 159 (2005) 824-834
95. Manju M., Chmielowiec S., Andres R., et al. Cocaine alters placental production of thromboxane and prostacyclin. Am J Obstet Gynecol 171 (1994) 965-969